Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation

Biochemical and Biophysical Research Communications

Volumn 418, Issue 2, 2012, Pages 247-253

  Moon, Ho Jin ^a   Ko, Wan Kyu ^a   Han, Song Wook ^b   Kim, Duck Su ^a   Hwang, Yu Shik ^a   Park, Hun Kuk ^b   Kwon, Il Keun ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Coenzyme Q10; Curcumin; Osteoclast; Reactive oxygen species; Selenium

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CURCUMIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SODIUM SELENITE; TRANSCRIPTION FACTOR NFAT; UBIDECARENONE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GENE INDUCTION; GENETIC MARKER; MONOCYTE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL LINE; CURCUMIN; DOWN-REGULATION; GENE EXPRESSION; I-KAPPA B PROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; REACTIVE OXYGEN SPECIES; SODIUM SELENITE; UBIQUINONE;

EID: 84862830701     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.005     Document Type: Article

References (21)

1. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 2003, 4:638-649.
2. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 1999, 20:345-357.
3. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
4. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
5. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
6. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 1990, 85:632-639.
7. Ha H., Kwak H.B., Lee S.W., Jin H.M., Kim H.M., Kim H.H., Lee Z.H. Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. Cell Res. 2004, 301:119-127.
8. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., Kim N., Lee S.Y. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
9. Deichmann R., Lavie C., Andrews S. Coenzyme Q10 and statin-induced mitochondrial dysfunction. Ochsner. J. 2010, 10:16-21.
10. Caffrey P.B., Frenkel G.D. Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo. Cancer Chemother. Pharmacol. 2000, 46:74-78.
11. Epp O., Ladenstein R., Wendel A. The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution. Eur. J. Biochem. 1983, 133:51-69.
12. Chung Y.W., Kim T.S., Lee S.Y., Lee S.H., Kim Y.N., Min B.M., Jeong D.W., Kim I.Y. Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway. Toxicol. Lett. 2006, 160:143-150.
13. Somparn P., Phisalaphong C., Nakornchai S., Unchern S., Morales N.P. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharm. Bull. 2007, 30:74-78.
14. Kluth D., Banning A., Paur I., Blomhoff R., Brigelius-Flohé R. Modulation of pregnane X receptor and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic. Biol. Med. 2007, 42:315-325.
15. Bharti A.C., Takada Y., Aggarwal B.B. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 2004, 172:5940-5947.
16. Lee S.E., Woo K.M., Kim S.Y., Kim H.M., Kwack K., Lee Z.H., Kim H.H. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 2002, 30:71-77.
17. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
18. Kim H.J., Chang E.J., Kim H.M., Lee S.B., Kim H.D., Su Kim G., Kim H.H. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic. Biol. Med. 2006, 40:1483-1493.
19. Yamashita M., Otsuka F., Mukai T., Yamanaka R., Otani H., Matsumoto Y., Nakamura E., Takano M., Sada K.E., Makino H. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul. Pept. 2010, 162:99-108.
20. Moon H.J., Kim S.E., Yun Y.P., Hwang Y.S., Park J.H., Kwon I.K. The inhibitory effect of simvastatin on osteoclast differentiation by scavenging reactive oxygen species. Exp. Mol. Med. 2011, 11:605-612.
21. Srinivasan S., Koenigstein A., Joseph J., Sun L., Kalyanaraman B., Zaidi M., Avadhani N.G., Ann N.Y. Role of mitochondrial reactive oxygen species in osteoclast differentiation. Acad. Sci. 2010, 1192:245-252.